Avere Therapeutics Announces $500 Million Private Placement
August 11, 2026
August 11, 2026
PALO ALTO, California, Aug. 11 -- Cooley, a law firm, issued the following news release:
* * *
Avere Therapeutics Announces $500 Million Private Placement
Cooley advised Jefferies, TD Cowen, Evercore ISI, UBS Investment Bank and Wedbush & Co., LLC as the placement agents to Avere Therapeutics, a privately held biotechnology company advancing oral therapies for IL-23 driven inflammatory diseases, in connection with a $500 million private placement from a . . .
* * *
Avere Therapeutics Announces $500 Million Private Placement
Cooley advised Jefferies, TD Cowen, Evercore ISI, UBS Investment Bank and Wedbush & Co., LLC as the placement agents to Avere Therapeutics, a privately held biotechnology company advancing oral therapies for IL-23 driven inflammatory diseases, in connection with a $500 million private placement from a . . .